Effect of acute exacerbations on skeletal muscle strength and physical activity in cystic fibrosis

Journal of Cystic Fibrosis

Volumn 11, Issue 3, 2012, Pages 209-215

  Wieboldt, Jason ^a   Atallah, Louis ^b   Kelly, Julia L ^a   Shrikrishna, Dinesh ^a   Gyi, Khin M ^a   Lo, Benny ^b   Yang, Guang Zhong ^b   Bilton, Diana ^a   Polkey, Michael I ^a   Hopkinson, Nicholas S ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Exacerbation; Physical activity; Skeletal muscle

Indexed keywords

ACCELEROMETER; ADULT; ARTICLE; BREATHING MUSCLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION COEFFICIENT; CYSTIC FIBROSIS; DISEASE EXACERBATION; FEMALE; HOSPITAL ADMISSION; HUMAN; LIMB WEAKNESS; MALE; MUSCLE STRENGTH; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MOTOR ACTIVITY; MUSCLE STRENGTH; MUSCLE STRENGTH DYNAMOMETER; PROGNOSIS; PROSPECTIVE STUDIES; QUADRICEPS MUSCLE; RESPIRATORY MUSCLES; SEVERITY OF ILLNESS INDEX; SPIROMETRY;

EID: 84860600969     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.12.001     Document Type: Article

References (41)

1. Seymour J.M., Spruit M.A., Hopkinson N.S., Natanek S.A., Man W.D.-C., Jackson A., et al. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010, 36:81-88.
2. Nishiyama O., Taniguchi H., Kondoh Y., Kimura T., Ogawa T., Watanabe F., et al. Quadriceps weakness is related to exercise capacity in idiopathic pulmonary fibrosis. Chest 2005, 127:2028-2033.
3. Swallow E.B., Reyes D., Hopkinson N.S., Man W.D., Porcher R., Cetti E.J., et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007, 62:115-120.
4. Oppenheimer E.H. Focal necrosis of striated muscle in an infant with cystic fibrosis of the pancreas and evidence of lack of absorption of fat-soluble vitamins. Bull Johns Hopkins Hosp 1956, 98:353-359.
5. Troosters T., Langer D., Vrijsen B., Segers J., Wouters K., Janssens W., et al. Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis. Eur Respir J 2009, 33:99-106.
6. Barry S.C., Gallagher C.G. Corticosteroids and skeletal muscle function in cystic fibrosis. J Appl Physiol 2003, 95:1379-1384.
7. Pinet C., Cassart M., Scillia P., Lamotte M., Knoop C., Casimir G., et al. Function and bulk of respiratory and limb muscles in patients with cystic fibrosis. Am J Respir Crit Care Med 2003, 168:989-994.
8. Pinet C., Scillia P., Cassart M., Lamotte M., Knoop C., Melot C., et al. Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis. Thorax 2004, 59:783-789.
9. Elkin S.L., Williams L., Moore M., Hodson M.E., Rutherford O.M. Relationship of skeletal muscle mass, muscle strength and bone mineral density in adults with cystic fibrosis. Clin Sci (Lond) 2000, 99:309-314.
10. Hussey J., Gormley J., Leen G., Greally P. Peripheral muscle strength in young males with cystic fibrosis. J Cyst Fibros 2002, 1:116-121.
11. Spruit M.A., Gosselink R., Troosters T., Kasran A., Gayan-Ramirez G., Bogaerts P., et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003, 58:752-756.
12. Pitta F., Troosters T., Probst V.S., Spruit M.A., Decramer M., Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006, 129:536-544.
13. Hopkinson N.S., Tennant R.C., Dayer M.J., Swallow E.B., Hansel T.T., Moxham J., et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007, 8:25.
14. Divangahi M., Balghi H., Danialou G., Comtois A.S., Demoule A., Ernest S., et al. Lack of CFTR in skeletal muscle predisposes to muscle wasting and diaphragm muscle pump failure in cystic fibrosis mice. PLoS Genet 2009, 5:e1000586.
15. Lamhonwah A.M., Bear C.E., Huan L.J., Kim Chiaw P., Ackerley C.A., Tein I. Cystic fibrosis transmembrane conductance regulator in human muscle: dysfunction causes abnormal metabolic recovery in exercise. Ann Neurol 2010, 67:802-808.
16. Wells G.D., Wilkes D.L., Schneiderman J.E., Rayner T., Elmi M., Selvadurai H., et al. Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res 2011, 69:40-45.
17. Aziz O., Atallah L., Lo B., ElHelw M., Wang L., Yang G.Z., et al. A pervasive body sensor network for measuring postoperative recovery at home. Surg Innov 2007, 14:83-90.
18. Edwards R.H., Young A., Hosking G.P., Jones D.A. Human skeletal muscle function: description of tests and normal values. Clin Sci Mol Med 1977, 52:283-290.
19. Uldry C., Janssens J.P., de Muralt B., Fitting J.W. Sniff nasal inspiratory pressure in patients with chronic obstructive pulmonary disease. Eur Respir J 1997, 10:1292-1296.
20. Wilson S.H., Cooke N.T., Edwards R.H.T., Spiro S.G. Predicted normal values for maximal respiratory pressures in caucasian adults and children. Thorax 1984, 39:535-538.
21. Atallah L., Leong J.J., Lo B., Yang G.Z. Energy expenditure prediction using a miniaturised ear-worn sensor. Med Sci Sports Exerc 2011, 43(7):1369-1377.
22. Atallah L., Lo B., Ali R., King R., Yang G.Z. Real-time activity classification using ambient and wearable sensors. IEEE Trans Inf Technol Biomed 2009, 13:1031-1039.
23. Aziz O., Atallah L., Lo B., Gray E., Athanasiou T., Darzi A., et al. Ear-worn body sensor network device: an objective tool for functional postoperative home recovery monitoring. J Am Med Inform Assoc 2011, 18:156-159.
24. Darby C.W., Davidson A.G., Desai I.D. Muscular performance in cystic fibrosis patients and its relation to vitamin E. Arch Dis Child 1973, 48:72-75.
25. de Meer K., Gulmans V.A., van Der Laag J. Peripheral muscle weakness and exercise capacity in children with cystic fibrosis. Am J Respir Crit Care Med 1999, 159:748-754.
26. Ionescu A.A., Mickleborough T.D., Bolton C.E., Lindley M.R., Nixon L.S., Dunseath G., et al. The systemic inflammatory response to exercise in adults with cystic fibrosis. J Cyst Fibros 2006, 5:105-112.
27. Dufresne V., Knoop C., Van Muylem A., Malfroot A., Lamotte M., Opdekamp C., et al. Effect of systemic inflammation on inspiratory and limb muscle strength and bulk in cystic fibrosis. Am J Respir Crit Care Med 2009, 180:153-158.
28. Vallier J.M., Gruet M., Mely L., Pensini M., Brisswalter J. Neuromuscular fatigue after maximal exercise in patients with cystic fibrosis. J Electromyogr Kinesiol 2011, 21:242-248.
29. de Meer K., Jeneson J.A., Gulmans V.A., van der Laag J., Berger R. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax 1995, 50:980-983.
30. Dunnink M.A., Doeleman W.R., Trappenburg J.C., de Vries W.R. Respiratory muscle strength in stable adolescent and adult patients with cystic fibrosis. J Cyst Fibros 2009, 8:31-36.
31. Mier A., Redington A., Brophy C., Hodson M., Green M. Respiratory muscle function in cystic fibrosis. Thorax 1990, 45:750-752.
32. O'Neill S., Leahy F., Pasterkamp H., Tal A. The effects of chronic hyperinflation, nutritional status, and posture on respiratory muscle strength in cystic fibrosis. Am Rev Respir Dis 1983, 128:1051-1054.
33. Marks J., Pasterkamp H., Tal A., Leahy F. Relationship between respiratory muscle strength, nutritional status, and lung volume in cystic fibrosis and asthma. Am Rev Respir Dis 1986, 133:414-417.
34. Enright S., Chatham K., Ionescu A.A., Unnithan V.B., Shale D.J. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. J Cyst Fibros 2007, 6:384-390.
35. Szeinberg A., England S., Mindorff C., Fraser I.M., Levison H. Maximal inspiratory and expiratory pressures are reduced in hyperinflated, malnourished, young adult male patients with cystic fibrosis. Am Rev Respir Dis 1985, 132:766-769.
36. Pradal U., Polese G., Braggion C., Poggi R., Zanolla L., Mastella G., et al. Determinants of maximal transdiaphragmatic pressure in adults with cystic fibrosis. Am J Respir Crit Care Med 1994, 150:167-173.
37. Hart N., Tounian P., Clement A., Boule M., Polkey M.I., Lofaso F., et al. Nutritional status is an important predictor of diaphragm strength in young patients with cystic fibrosis. Am J Clin Nutr 2004, 80:1201-1206.
38. Hopkinson N.S., Dayer M.J., Moxham J., Polkey M.I. Abdominal muscle fatigue following exercise in chronic obstructive pulmonary disease. Respir Res 2010, 11:15.
39. Cerny F., Armitage L., Hirsch J.A., Bishop B. Respiratory and abdominal muscle responses to expiratory threshold loading in cystic fibrosis. J Appl Physiol 1992, 72:842-850.
40. Hopkinson N.S., Man W.D., Dayer M.J., Ross E.T., Nickol A.H., Hart N., et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 2004, 24:137-142.
41. Hopkinson N.S., Nickol A.H., Payne J., Hawe E., Man W.D., Moxham J., et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004, 170:395-399.